Tracking T-cells in vivo with a new nano-sized MRI contrast agent

Abstract Non-invasive in vivo tracking of T-cells by magnetic resonance imaging (MRI) can lead to a better understanding of many pathophysiological situations, including AIDS, cancer, diabetes, graft rejection. However, an efficient MRI contrast agent and a reliable technique to track non-phagocytic...

Ausführliche Beschreibung